
TriMas Corporation (NASDAQ:TRS - Free Report) - Equities researchers at Zacks Research decreased their Q3 2026 earnings per share estimates for shares of TriMas in a research note issued to investors on Wednesday, June 25th. Zacks Research analyst M. Das now expects that the industrial products company will post earnings of $0.53 per share for the quarter, down from their previous estimate of $0.58. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. Zacks Research also issued estimates for TriMas' Q4 2026 earnings at $0.41 EPS, FY2026 earnings at $1.92 EPS, Q1 2027 earnings at $0.48 EPS and FY2027 earnings at $1.96 EPS.
TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The industrial products company reported $0.46 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.03. The company had revenue of $241.67 million for the quarter, compared to the consensus estimate of $235.41 million. TriMas had a return on equity of 10.54% and a net margin of 3.36%. The firm's quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 EPS.
A number of other equities research analysts have also recently commented on TRS. Wall Street Zen upgraded shares of TriMas from a "hold" rating to a "buy" rating in a research note on Sunday, June 1st. BWS Financial reaffirmed a "buy" rating and set a $40.00 target price on shares of TriMas in a research note on Wednesday, April 30th.
Check Out Our Latest Stock Analysis on TriMas
TriMas Stock Performance
Shares of TRS stock traded up $0.25 on Friday, reaching $28.63. The stock had a trading volume of 227,578 shares, compared to its average volume of 356,604. TriMas has a 1 year low of $19.33 and a 1 year high of $28.77. The stock has a market cap of $1.16 billion, a P/E ratio of 37.18 and a beta of 0.61. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.49 and a current ratio of 2.82. The company has a 50 day simple moving average of $25.36 and a 200 day simple moving average of $24.10.
TriMas Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, May 13th. Stockholders of record on Tuesday, May 6th were given a $0.04 dividend. This represents a $0.16 annualized dividend and a dividend yield of 0.56%. The ex-dividend date was Tuesday, May 6th. TriMas's payout ratio is 20.78%.
Insider Activity at TriMas
In other news, Director Shawn Sedaghat purchased 254,400 shares of the firm's stock in a transaction on Monday, May 19th. The shares were bought at an average cost of $25.39 per share, for a total transaction of $6,459,216.00. Following the completion of the purchase, the director now directly owns 1,295,692 shares of the company's stock, valued at approximately $32,897,619.88. This trade represents a 24.43% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Adrianne Shapira acquired 1,200 shares of the stock in a transaction dated Wednesday, June 4th. The stock was acquired at an average cost of $26.31 per share, with a total value of $31,572.00. Following the purchase, the director now owns 4,476 shares of the company's stock, valued at approximately $117,763.56. This trade represents a 36.63% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased a total of 971,649 shares of company stock valued at $24,585,343 over the last quarter. 14.20% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently added to or reduced their stakes in TRS. Bank of America Corp DE boosted its holdings in shares of TriMas by 127.3% in the fourth quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock valued at $86,400,000 after acquiring an additional 1,967,738 shares during the period. Bellecapital International Ltd. acquired a new stake in TriMas in the fourth quarter valued at $29,160,000. Irenic Capital Management LP purchased a new position in shares of TriMas during the 1st quarter worth approximately $19,997,000. Alta Fox Capital Management LLC acquired a new position in TriMas in the 1st quarter valued at about $17,385,000. Finally, Simcoe Capital Management LLC acquired a new position in TriMas in the first quarter valued at $6,451,000. Hedge funds and other institutional investors own 99.42% of the company's stock.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Featured Articles

Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report